Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03227016
Title Study in Patients With SCLC of Veliparib in Combination With Topotecan
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Central European Society for Anticancer Drug Research

lung small cell carcinoma


Topotecan + Veliparib

Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.